» Articles » PMID: 26872597

Therapies Targeting Lipid Peroxidation in Traumatic Brain Injury

Overview
Journal Brain Res
Specialty Neurology
Date 2016 Feb 14
PMID 26872597
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Lipid peroxidation can be broadly defined as the process of inserting a hydroperoxy group into a lipid. Polyunsaturated fatty acids present in the phospholipids are often the targets for peroxidation. Phospholipids are indispensable for normal structure of membranes. The other important function of phospholipids stems from their role as a source of lipid mediators - oxygenated free fatty acids that are derived from lipid peroxidation. In the CNS, excessive accumulation of either oxidized phospholipids or oxygenated free fatty acids may be associated with damage occurring during acute brain injury and subsequent inflammatory responses. There is a growing body of evidence that lipid peroxidation occurs after severe traumatic brain injury in humans and correlates with the injury severity and mortality. Identification of the products and sources of lipid peroxidation and its enzymatic or non-enzymatic nature is essential for the design of mechanism-based therapies. Recent progress in mass spectrometry-based lipidomics/oxidative lipidomics offers remarkable opportunities for quantitative characterization of lipid peroxidation products, providing guidance for targeted development of specific therapeutic modalities. In this review, we critically evaluate previous attempts to use non-specific antioxidants as neuroprotectors and emphasize new approaches based on recent breakthroughs in understanding of enzymatic mechanisms of lipid peroxidation associated with specific death pathways, particularly apoptosis. We also emphasize the role of different phospholipases (calcium-dependent and -independent) in hydrolysis of peroxidized phospholipids and generation of pro- and anti-inflammatory lipid mediators. This article is part of a Special Issue entitled SI:Brain injury and recovery.

Citing Articles

Aminophylline targets miR-128-3p/Slc7a11 axis to attenuate neuronal ferroptosis after traumatic brain injury.

Manrui L, Xu Y, Liu J, Zhang X, Yuan R, Sun Y Cell Mol Life Sci. 2025; 82(1):87.

PMID: 39985589 PMC: 11846823. DOI: 10.1007/s00018-025-05601-3.


Mechanism and prospects of mitochondrial transplantation for spinal cord injury treatment.

Wang Q, Wang X, Shang Z, Zhao L Stem Cell Res Ther. 2024; 15(1):457.

PMID: 39609871 PMC: 11606159. DOI: 10.1186/s13287-024-04077-5.


Raloxifene Protects Oxygen-Glucose-Deprived Astrocyte Cells Used to Mimic Hypoxic-Ischemic Brain Injury.

Toro-Urrego N, Luaces J, Kobiec T, Udovin L, Bordet S, Otero-Losada M Int J Mol Sci. 2024; 25(22).

PMID: 39596189 PMC: 11594051. DOI: 10.3390/ijms252212121.


A simultaneous analysis strategy of glycerophospholipids and lipid mediators based on secondary extraction scheme.

Zhang Y, Ding C, Xu J, Kong L, Wang Y, Lin W Anal Bioanal Chem. 2024; 417(1):109-117.

PMID: 39516289 DOI: 10.1007/s00216-024-05629-7.


Tetramerization of PKM2 Alleviates Traumatic Brain Injury by Ameliorating Mitochondrial Damage in Microglia.

Zhu H, Zhang H, Zhao X, Zhang L, Liu X, Zhang Z J Neuroimmune Pharmacol. 2024; 19(1):48.

PMID: 39196455 DOI: 10.1007/s11481-024-10138-6.


References
1.
Ames B, Shigenaga M, Hagen T . Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993; 90(17):7915-22. PMC: 47258. DOI: 10.1073/pnas.90.17.7915. View

2.
Robak J, Gryglewski R . Nitric oxide donors as generators and scavengers of superoxide anions. Pol J Pharmacol. 1993; 45(1):51-8. View

3.
Evans P . Free radicals in brain metabolism and pathology. Br Med Bull. 1993; 49(3):577-87. DOI: 10.1093/oxfordjournals.bmb.a072632. View

4.
Chan A . Partners in defense, vitamin E and vitamin C. Can J Physiol Pharmacol. 1993; 71(9):725-31. DOI: 10.1139/y93-109. View

5.
Dennis E . Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994; 269(18):13057-60. View